Investigating the impact of combining handwritten signature and keyboard keystroke dynamics for gender prediction

© 2019 IEEE. The use of soft-biometric data as an auxiliary tool on user identification is already well known. Gender, handorientation and emotional state are some examples which can be called soft-biometrics. These soft-biometric data can be predicted directly from the biometric templates. It is very common to find researches using physiological modalities for soft-biometric prediction, but behavioural biometric is often not well explored for this context. Among the behavioural biometric modalities, keystroke dynamics and handwriting signature have been widely explored for user identification, including some soft-biometric predictions. However, in these modalities, the soft-biometric prediction is usually done in an individual way. In order to fill this space, this study aims to investigate whether the combination of those two biometric modalities can impact the performance of a soft-biometric data, gender prediction. The main aim is to assess the impact of combining data from two different biometric sources in gender prediction. Our findings indicated gains in terms of performance for gender prediction when combining these two biometric modalities, when compared to the individual ones

Combining neural networks and fuzzy logic for applications in character recognition

SIGLEAvailable from British Library Document Supply Centre-DSC:DXN044016 / BLDSC - British Library Document Supply CentreGBUnited Kingdo

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN